Sfoglia per AUTORE
ATTILI I
Collezione AOU San Luigi di Orbassano
Items : 3
Immunotherapy in advanced non-small cell lung cancer: What to do for the 'Invisible' patients after IPSOS trial results? in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2025 Mar 7;202:108482. doi: 10.1016/j.lungcan.2025.108482.
2025
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Gridelli C; Attili I; Bennati C; Bironzo P; Bria E; Cortinovis DL; Soto Parra H; de Marinis F;
Pralsetinib in RET fusion-positive non-small-cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP). in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2022 Dec;174:118-124. doi: 10.1016/j.lungcan.2022.11.005. Epub 2022 Nov 9.
2022
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Passaro A; Russo GL; Passiglia F; D'Arcangelo M; Sbrana A; Russano M; Bonanno L; Giusti R; Metro G; Bertolini F; Grisanti S; Carta A; Cecere F; Montrone M; Massa G; Perrone F; Simionato F; Guaitoli G; Scotti V; Genova C; Lugini A; Bonomi L; Attili I; de Marinis F;
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features. in Cancers / Cancers (Basel). 2021 Jun 11;13(12):2935. doi: 10.3390/cancers13122935.
2021
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Passaro A; Novello S; Giannarelli D; Bria E; Galetta D; Gelibter A; Reale ML; Carnio S; Vita E; Stefani A; Pizzutilo P; Stati V; Attili I; de Marinis F;